SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-204483
Filing Date
2023-08-07
Accepted
2023-08-07 07:49:23
Documents
6
Effectiveness Date
2023-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 d538586ds8.htm S-8 33652
2 EX-5.1 d538586dex51.htm EX-5.1 8678
3 EX-23.1 d538586dex231.htm EX-23.1 1510
4 EX-FILING FEES d538586dexfilingfees.htm EX-FILING FEES 14098
5 GRAPHIC g538586page7a.jpg GRAPHIC 1834
6 GRAPHIC g538586page7b.jpg GRAPHIC 5796
  Complete submission text file 0001193125-23-204483.txt   69693
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273754 | Film No.: 231145636
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences